Hydroxyzine Hydrochloride Tablets had U.S. sales of approximately $55 million for the 12 months ending March 31, 2010, according to IMS Health.

HCL Technologies plans to set up a BPO delivery facility in the Philippines by the end of its current financial year ended June 2012.

According to the notification, pharmaceutical companies have been ordered to immediately stop manufacturing all formulations containing a combination of Theophyline, Ephedrine HCL, Hydroxyzine and ...